CME Presentations
Ovarian Cancer
Navigating the Use of PARP Inhibitors to Treat Ovarian Cancer
Speakers: Paul DiSilvestro, MD, Professor, Obstetrics and Gynecology, Director, Division of Gynecologic Oncology Duration: 38 minutes
Presented on: November 8, 2022
Multi-Cancer Early Detection
Early Detection of Women’s Cancers: A Prominent Role for Primary Care and OB/GYNs
Speakers: Lisa Larkin, MD, FACP, NCMP, IF, Founder and CEOMylynda Massart, MD, PhD, Assistant Professor, Department of Family Medicine Duration: 60 minutes
Presented on: February 1, 2023
EGFR TKI-Resistant NSCLC and HER2-Positive NSCLC
Expert Insight into Emerging Treatments for EGFR TKI Resistant NSCLC and HER2 Positive NSCLC
Speakers: Lyudmila Bazhenova, MD, Program DirectorPasi Jänne, MD, PhD, Professor of Medicine Duration: 60 minutes
Presented on: February 15, 2023
HER2+ mCRC
A New Path for HER2-positive Metastatic Colorectal Cancer
Speakers: John Strickler, MD, Associate ProfessorTanios Bekaii-Saab, MD, FACP, Professor of Medicine Duration: 60 minutes
Presented on: February 8, 2023
Melanoma
Applying a Patient-centered Approach to Unresectable and Metastatic Melanoma
Duration: 60 minutes
Presented on: February 13, 2023
HCC
Decoding the Nuances of Diagnosis and Emerging Therapeutic Options in HCC
Speakers: Amit Singal, Clinical Chief of Hepatology ProfessorGhassan Abou-Alfa, MD, MBA, Professor Duration: 60 minutes
Presented on: March 29, 2023
NHL
Collaborating with Patients to Achieve Clinical Trial Equity in Non‐Hodgkin Lymphoma
Duration: 60 minutes
Presented on: March 1, 2023
MDS
Strategies to Address Real-World Challenges in High-Risk Myelodysplastic Syndrome
Speakers: Naval Daver, MD, Associate ProfessorDavid Sallman, MD, Assistant Member, Department of Malignant Hematology (DMH) Duration: 60 minutes
Presented on: April 6, 2023
TNBC
A Changing Approach to TNBC Management: Patients as Partners in Care
Speakers: Tiffany Traina, MD, FASCO, Vice Chair, Oncology CareStephanie Walker, Retired RN living with MBC de novo since July 2015Gregory Gregory Vidal, MD, PhD, Medical Oncologist Duration: 60 minutes
Presented on: June 29, 2023
Multiple Myeloma
Placing Bispecific Antibodies in the Treatment Landscape for Heavily Pretreated Multiple Myeloma
Speakers: Attaya Suvannasankha, MD, Associate Professor, Clinical MedicineHans Lee, MD, Associate Professor, Department of Lymphoma/Myeloma Duration: 60 minutes
Presented on: September 21, 2023